Integrity Laboratories began testing for SARS-CoV-2 (COVID-19) under Emergency Use Authorization (EUA) on March 23.
Please direct all inquiries to covid19@integritylaboratories.com for immediate review.
Click Here for CDC recommendations for Identifying Monkeypox.